Search
Now showing items 1-6 of 6
Coronavirus SARS-CoV-2: ús extrahospitalari de la hidroxicloroquina [fullet]
(2020-05-06)
Recommendations for the initiation and follow-up of hydroxychloroquine treatment in the SARS-CoV-2 pneumonia in the outpatient setting.
Coronavirus SARS-CoV-2: actualització de la nota informativa en relació a l’ús dels IECA i els ARA-II i la COVID-19 [fullet]
(2020-06-06)
Study updating international information related to the use of angiotensin converting enzyme inhibitors (ACE inhibitors) and angiotensin II receptor antagonists (ARA-II) with COVID-19.
Coronavirus SARS-CoV-2: actualització de les recomanacions de tractament farmacològic de la pneumònia lleu-moderada [fullet]
(2020-04-19)
Specific treatments for COVID-19 require pneumonia diagnosis and confirmation of SARS-CoV-2 coronavirus infection by PCR or rapid test. Although confirmed pneumonia treatment requires hospitalization, in some cases it may ...
Coronavirus SARS-CoV-2: nota informativa sobre la seguretat dels inhibidors del cotransportador sodi-glucosa tipus 2 (ISGLT2) en el context de la crisi de la COVID-19 [fullet]
(2020-04-15)
Recommendations on ISGLT2 treatment have been published in the context of SARS-CoV-2 coronavirus infection from a single English-language hospital consortium, which have not been assumed by the rest of the British NHS. ...
Coronavirus SARS-CoV-2: nota informativa sobre el maneig de la teràpia hormonal de la menopausa i el tractament anticonceptiu en la COVID-19 [fullet]
(2020-05-01)
The aim of this paper is to describe the considerations to be considered in women treated with menopausal hormone therapy (THM) or combined hormonal contraception (AHC) in the context of a coronavirus infection or suspected ...